Back to mobile site

Exact Sciences Corp (EXAS) Misses Q1 Expectations

May 1, 2014 9:11 AM EDT

Exact Sciences Corp (NASDAQ: EXAS) reported Q1 EPS of ($0.23), $0.04 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $294 thousand versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings